X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (42566) 42566
Newspaper Article (962) 962
Newsletter (806) 806
Book Chapter (262) 262
Magazine Article (207) 207
Book / eBook (115) 115
Dissertation (106) 106
Conference Proceeding (35) 35
Web Resource (33) 33
Government Document (30) 30
Trade Publication Article (25) 25
Publication (21) 21
Book Review (12) 12
Report (9) 9
Reference (4) 4
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28153) 28153
diabetes (26273) 26273
female (18743) 18743
male (17593) 17593
middle aged (13737) 13737
diabetes mellitus (12149) 12149
adult (12041) 12041
risk factors (11540) 11540
aged (10371) 10371
type 2 diabetes (9527) 9527
endocrinology & metabolism (9312) 9312
prevalence (7768) 7768
obesity (7113) 7113
research (6937) 6937
mortality (6112) 6112
studies (6087) 6087
analysis (5820) 5820
health aspects (5381) 5381
hypertension (5309) 5309
mellitus (5031) 5031
insulin (5005) 5005
glucose (4928) 4928
care and treatment (4896) 4896
population (4895) 4895
risk (4875) 4875
medicine (4612) 4612
adolescent (4492) 4492
public health (4450) 4450
epidemiology (4438) 4438
body mass index (4424) 4424
patients (4307) 4307
public, environmental & occupational health (4285) 4285
cardiovascular disease (4227) 4227
socioeconomic factors (4086) 4086
research article (3986) 3986
adults (3839) 3839
medicine & public health (3727) 3727
medicine, general & internal (3711) 3711
cross-sectional studies (3606) 3606
young adult (3534) 3534
medical research (3429) 3429
diabetes mellitus, type 2 - epidemiology (3403) 3403
health (3370) 3370
disease (3363) 3363
prevention (3299) 3299
diabetes therapy (3240) 3240
management (3158) 3158
internal medicine (3141) 3141
aged, 80 and over (3117) 3117
diabetics (3055) 3055
risk-factors (3006) 3006
blood pressure (2971) 2971
age (2907) 2907
cardiovascular diseases (2907) 2907
diabetes mellitus, type 2 - drug therapy (2854) 2854
glycemic control (2811) 2811
diet (2783) 2783
quality of life (2669) 2669
diagnosis (2662) 2662
metabolic syndrome (2631) 2631
insulin resistance (2623) 2623
multidisciplinary sciences (2614) 2614
hypoglycemic agents - therapeutic use (2570) 2570
child (2561) 2561
association (2531) 2531
diabetes mellitus - epidemiology (2506) 2506
health care (2427) 2427
complications (2414) 2414
chronic illnesses (2366) 2366
diabetes mellitus, type 2 - complications (2366) 2366
comorbidity (2355) 2355
children (2342) 2342
hospitals (2309) 2309
health risk assessment (2308) 2308
exercise (2288) 2288
medicine, experimental (2273) 2273
surveys and questionnaires (2273) 2273
pregnancy (2252) 2252
metabolism (2247) 2247
type 2 diabetes mellitus (2240) 2240
animals (2233) 2233
retrospective studies (2200) 2200
hyperglycemia (2174) 2174
care (2165) 2165
nutrition & dietetics (2164) 2164
cohort studies (2154) 2154
regression analysis (2137) 2137
science (2116) 2116
treatment outcome (2100) 2100
endocrinology (2099) 2099
type 1 diabetes (2093) 2093
diabetes-mellitus (2067) 2067
nutrition (2049) 2049
women (2047) 2047
cardiovascular-disease (2038) 2038
health care sciences & services (2014) 2014
incidence (2010) 2010
insulin-resistance (2000) 2000
intervention (1989) 1989
cholesterol (1984) 1984
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (27) 27
Gerstein Science - Stacks (22) 22
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Baycrest Hospital - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Media Commons - Microtexts (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Reference (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44859) 44859
Portuguese (241) 241
Spanish (117) 117
German (106) 106
French (86) 86
Japanese (34) 34
Russian (30) 30
Norwegian (29) 29
Arabic (20) 20
Turkish (17) 17
Polish (14) 14
Swedish (14) 14
Chinese (11) 11
Danish (11) 11
Italian (11) 11
Czech (8) 8
Dutch (6) 6
Slovenian (5) 5
Afrikaans (4) 4
Hungarian (4) 4
Serbian (4) 4
Korean (3) 3
Lithuanian (3) 3
Hebrew (2) 2
Persian (2) 2
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dzongkha (1) 1
Finnish (1) 1
Slovak (1) 1
Ukrainian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes care, ISSN 1935-5548, 2018, Volume 41, Issue 8, pp. 1579 - 1589
...) systems has gained wide acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, improving glycemic control and reducing risks of hypoglycemia in ambulatory patients with type 1 diabetes and type 2 diabetes... 
MULTIPLE DAILY INJECTIONS | ARTIFICIAL PANCREAS | INTENSIVE-CARE-UNIT | AMERICAN ASSOCIATION | ENDOCRINOLOGY & METABOLISM | CLINICAL-PRACTICE GUIDELINE | ASSOCIATION CONSENSUS STATEMENT | INPATIENT GLYCEMIC CONTROL | BASAL-BOLUS INSULIN | CRITICALLY-ILL PATIENTS | CLOSED-LOOP SYSTEM | Blood Glucose Self-Monitoring - economics | Diabetes Mellitus, Type 1 - epidemiology | Insulin - economics | Risk Reduction Behavior | Humans | Hospitalization - statistics & numerical data | Diabetes Mellitus, Type 2 - economics | Insulin - administration & dosage | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Blood Glucose - drug effects | Blood Glucose Self-Monitoring - methods | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 1 - economics | Cost-Benefit Analysis | Diabetes Mellitus, Type 1 - blood | Insulin Infusion Systems - economics | Blood Glucose - metabolism | Blood Glucose Self-Monitoring - instrumentation | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Insulin - adverse effects | Hospitalization - economics | Diabetics | Usage | Control | Care and treatment | Glucose monitors | Analysis | Insulin pumps | Clinical trials | Hypoglycemia | 0204 | 1032 | Symposium
Journal Article
Value in health, ISSN 1098-3015, 2011, Volume 14, Issue 5, pp. 665 - 671
Journal Article
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2017, Volume 66, Issue 2, pp. 241 - 255
Journal Article
Journal Article
Diabetic Medicine, ISSN 0742-3071, 04/2016, Volume 33, Issue 4, pp. 471 - 477
... 3a clinical programme involving people with Type 1 diabetes treated with basal–bolus insulin, people with Type... 
GLYCEMIC CONTROL | 26-WEEK | GLARGINE | NAIVE PATIENTS | ENDOCRINOLOGY & METABOLISM | OPEN-LABEL | TO-TARGET TRIAL | BEGIN | BASAL-BOLUS TREATMENT | TYPE-2 | DEGLUDEC/INSULIN ASPART | Hypoglycemia - therapy | Hypoglycemic Agents - economics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Insulin Detemir - therapeutic use | Insulin Detemir - economics | Clinical Trials, Phase III as Topic | Hypoglycemic Agents - administration & dosage | Hypoglycemic Agents - therapeutic use | Sitagliptin Phosphate - administration & dosage | Costs and Cost Analysis | Administration, Oral | Drug Therapy, Combination - economics | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Insulin Aspart - economics | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Insulin, Long-Acting - therapeutic use | Hypoglycemic Agents - adverse effects | Insulin Aspart - adverse effects | Cohort Studies | Insulin Aspart - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Diabetes Mellitus, Type 2 - economics | Insulin, Long-Acting - economics | Dipeptidyl-Peptidase IV Inhibitors - economics | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Insulin Aspart - administration & dosage | Insulin Detemir - administration & dosage | Insulin Detemir - adverse effects | Hypoglycemia - physiopathology | Adult | Hypoglycemia - economics | Hypoglycemia - chemically induced | Severity of Illness Index | Insulin Glargine - adverse effects | Drug Administration Schedule | Insulin Glargine - economics | Insulin Glargine - therapeutic use | Sitagliptin Phosphate - economics | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | Health Care Costs | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Sitagliptin Phosphate - adverse effects | Type 2 diabetes | Adults | Type 1 diabetes | Insulin | Analysis | Emergency medical care | Diabetes | Hypoglycemia | Complications | Research
Journal Article
Diabetes care, ISSN 1935-5548, 2018, Volume 41, Issue 6, pp. 1180 - 1187